Study Validating Esophageal Cancer Test Accepted by Gastroenterology Journal
The mass spectrometry-based assay achieved 100% sensitivity in detecting patients who later progressed to cancer in a blinded cohort study.
The mass spectrometry-based assay achieved 100% sensitivity in detecting patients who later progressed to cancer in a blinded cohort study.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab.
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.